Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
QuintilesIMS
Merck
Cipla
Moodys
McKesson
Colorcon
McKinsey
Dow
Chinese Patent Office

Generated: January 20, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,474,995

« Back to Dashboard

Summary for Patent: 5,474,995
Title: Phenyl heterocycles as cox-2 inhibitors
Abstract:The invention encompasses the novel compound of Formula I useful in the treatment of cyclooxygenase-2 mediated diseases, ##STR1## The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of Formula I.
Inventor(s): Ducharme; Yves (Montreal, CA), Gauthier; Jacques Y. (Laval, CA), Prasit; Petpiboon (Kirkland, CA), Leblanc; Yves (Kirkland, CA), Wang; Zhaoyin (Pierrefond, CA), Leger; Serge (Dollard Des Ormeaux, CA), Therien; Michel (Laval, CA)
Assignee: Merck Frosst Canada, Inc. (Kirkland, CA)
Application Number:08/179,467
Patent Claim Types:
see list of patent claims
Compound; Use; Composition;

Drugs Protected by US Patent 5,474,995

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 5,474,995

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 165825 ➤ Subscribe
Austria 212343 ➤ Subscribe
Australia 1269495 ➤ Subscribe
Australia 1913297 ➤ Subscribe
Australia 3613995 ➤ Subscribe
Australia 5621594 ➤ Subscribe
Australia 6197096 ➤ Subscribe
Australia 691119 ➤ Subscribe
Australia 6967494 ➤ Subscribe
Australia 711902 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
UBS
Boehringer Ingelheim
Fish and Richardson
Accenture
Fuji
McKinsey
Cipla
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot